271 related articles for article (PubMed ID: 37918254)
1. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX
Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254
[TBL] [Abstract][Full Text] [Related]
2. Tibetan Mesenchymal Stem Cell-derived Exosomes Alleviate Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension Rats.
Zhang Q; Liu H; Liu C; Wang Y; Huang P; Wang X; Ma Y; Ma L; Ge R
Stem Cells; 2024 May; ():. PubMed ID: 38717187
[TBL] [Abstract][Full Text] [Related]
3. [Effect of platelet-derived growth factor-BB on pulmonary vascular remodeling in neonatal rats with hypoxic pulmonary hypertension and its mechanism].
Guo X; Li MX; Bayer C; Yang YQ; Wang L
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Apr; 25(4):407-414. PubMed ID: 37073847
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling.
Zhang S; Liu X; Ge LL; Li K; Sun Y; Wang F; Han Y; Sun C; Wang J; Jiang W; Xin Q; Xu C; Chen Y; Chen O; Zhang Z; Luan Y
Respir Res; 2020 Mar; 21(1):71. PubMed ID: 32192495
[TBL] [Abstract][Full Text] [Related]
5. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.
Guo M; Zhang M; Cao X; Fang X; Li K; Qin L; He Y; Zhao J; Xu Y; Liu X; Li X
Respir Res; 2022 Jan; 23(1):6. PubMed ID: 35016680
[TBL] [Abstract][Full Text] [Related]
6. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
7. [Effects of human umbilical cord mesenchymal stem cells (MSCs)-derived exosomes on pulmonary vascular remodeling in hypoxic pulmonary hypertension].
Liu H; Zhang YW; Zhang QQ; Wang YX; Ge RL; Ma L
Sheng Li Xue Bao; 2024 Feb; 76(1):33-44. PubMed ID: 38444129
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1/PPAR-γaxis.
Zhang S; Liu J; Zheng K; Chen L; Sun Y; Yao Z; Sun Y; Lin Y; Lin K; Yuan L
Vascul Pharmacol; 2021 Feb; 136():106820. PubMed ID: 33238205
[TBL] [Abstract][Full Text] [Related]
9. The protective effects of MSC-EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathway.
Zhang Z; Ge L; Zhang S; Wang J; Jiang W; Xin Q; Luan Y
J Cell Mol Med; 2020 Dec; 24(23):13938-13948. PubMed ID: 33090702
[TBL] [Abstract][Full Text] [Related]
10. LncPTSR Triggers Vascular Remodeling in Pulmonary Hypertension by Regulating [Ca
Deng L; Chen J; Chen B; Wang T; Yang L; Liao J; Yi J; Chen Y; Wang J; Linneman J; Niu Y; Gou D
Am J Respir Cell Mol Biol; 2022 May; 66(5):524-538. PubMed ID: 35148256
[TBL] [Abstract][Full Text] [Related]
11. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
Zhao TF; Wang SY; Zou XZ; Zhao HD
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration.
Cao N; Aikeremu N; Shi WY; Tang XC; Gao RJ; Kong LJ; Zhang JR; Qin WJ; Zhang AM; Ma KT; Li L; Si JQ
Int J Mol Med; 2022 Sep; 50(3):. PubMed ID: 35856410
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stromal Cell-derived Exosomes Attenuate Experimental Pulmonary Arterial Hypertension.
Ge L; Jiang W; Zhang S; Wang J; Xin Q; Sun C; Li K; Qi T; Luan Y
Curr Pharm Biotechnol; 2021; 22(12):1654-1662. PubMed ID: 33390109
[TBL] [Abstract][Full Text] [Related]
14. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CapG in proliferation and apoptosis of pulmonary arterial smooth muscle cells and in hypoxia-induced pulmonary hypertension rat model.
Xu X; Hu H; Wang X; Ye W; Su H; Hu Y; Dong L; Zhang R; Ying K
Exp Lung Res; 2016 Apr; 42(3):142-53. PubMed ID: 27093378
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
[TBL] [Abstract][Full Text] [Related]
17. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
Kong D; Liu J; Lu J; Zeng C; Chen H; Duan Z; Yu K; Zheng X; Zou P; Zhou L; Lv Y; Zeng Q; Lu L; Li J; He Y
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):e172-e195. PubMed ID: 38572649
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine Kinase 1 Deficiency in Smooth Muscle Cells Protects against Hypoxia-Mediated Pulmonary Hypertension via YAP1 Signaling.
Chen J; Lockett A; Zhao S; Huang LS; Wang Y; Wu W; Tang M; Haider S; Velez Rendon D; Khan R; Liu B; Felesena N; Sysol JR; Valdez-Jasso D; Tang H; Bai Y; Natarajan V; Machado RF
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498853
[TBL] [Abstract][Full Text] [Related]
19. The effect of activated κ-opioid receptor (κ-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development.
Li J; Jia M; Liu M; Cao Z; Wang X; Feng N; Gu X; Zhang S; Fan R; Guo H; Wang Y; Liu M; Pei J
Biomed Pharmacother; 2020 May; 125():109931. PubMed ID: 32066040
[TBL] [Abstract][Full Text] [Related]
20. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
